SEARCH

SEARCH BY CITATION

References

  • 1
    Schwartz JC, Zhang X, Nathenson SG, Almo SC. Structural mechanisms of costimulation. Nat Immunol 2002; 3: 427434.
  • 2
    Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002; 3: 611618.
  • 3
    Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20: 2953.
  • 4
    Collins AV, Brodie DW, Gilbert RJ et al. The interaction properties of costimulatory molecules revisited. Immunity 2002; 17: 201210.
  • 5
    Grakoui A, Bromley SK, Sumen C et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999; 285: 221227.
  • 6
    Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569572.
  • 7
    Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest 2002; 109: 295299.
  • 8
    Greenwald RJ, Latchman YE, Sharpe AH. Negative co-receptors on lymphocytes. Curr Opin Immunol 2002; 14: 391396.
  • 9
    Bour-Jordan H, Blueston JA. CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol 2002; 22: 17.
  • 10
    Carreno BM, Bennett F, Chau TA et al. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 2000; 165: 13521356.
  • 11
    Riley JL, Mao M, Kobayashi S et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci USA 2002; 99: 1179011795.
  • 12
    Ostrov DA, Shi W, Schwartz JC, Almo SC, Nathenson SG. Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science 2000; 290: 816819.
  • 13
    Stamper CC, Zhang Y, Tobin JF et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 2001; 410: 608611.
  • 14
    Schwartz JC, Zhang X, Fedorov AA, Nathenson SG, Almo SC. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 2001; 410: 604608.
  • 15
    Nakaseko C, Miyatake S, Iida T et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J Exp Med 1999; 190: 765774.
  • 16
    Baroja ML, Luxenberg D, Chau T et al. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation. J Immunol 2000; 164: 4955.
  • 17
    Cinek T, Sadra A, Imboden JB. Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4. J Immunol 2000; 164: 58.
  • 18
    Masteller EL, Chuang E, Mullen AC, Reiner SL, Thompson CB. Structural analysis of CTLA-4 function in vivo. J Immunol 2000; 164: 53195327.
  • 19
    Shiratori T, Miyatake S, Ohno H et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 1997; 6: 583589.
  • 20
    Zhang Y, Allison JP. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. Proc Natl Acad Sci USA 1997; 94: 92739278.
  • 21
    Chuang E, Alegre ML, Duckett CS, Noel PJ, Vander Heiden MG, Thompson CB. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J Immunol 1997; 159: 144151.
  • 22
    Perez VL, Van Parijs L, Biuckians A, Zheng XX, Strom TB, Abbas AK. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997; 6: 411417.
  • 23
    Wells AD, Walsh MC, Bluestone JA, Turka LA. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest 2001; 108: 895903.
  • 24
    Greenwald RJ, Boussiotis VA, Lorsbach RB, Abbas AK, Sharpe AH. CTLA-4 regulates induction of anergy in vivo. Immunity 2001; 14: 145155.
  • 25
    Linsley PS, Nadler SG, Bajorath J et al. Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules. J Biol Chem 1995; 270: 1541715424.
  • 26
    Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 25412550.
  • 27
    Pioli C, Gatta L, Frasca D, Doria G. Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IkappaBalpha degradation and RelA activation. Eur J Immunol 1999; 29: 856863.
  • 28
    Delon J, Kaibuchi K, Germain RN. Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity 2001; 15: 691701.
  • 29
    Bromley SK, Burack WR, Johnson KG et al. The immunological synapse. Annu Rev Immunol 2001; 19: 375396.
  • 30
    Van Der Merwe PA, Davis SJ. Immunology. The immunological synapse – a multitasking system. Science 2002; 295: 14791480.
  • 31
    Lee KH, Holdorf AD, Dustin ML, Chan AC, Allen PM, Shaw AS. T cell receptor signaling precedes immunological synapse formation. Science 2002; 295: 15391542.
  • 32
    Blanchard N, Di Bartolo V, Hivroz C. In the immune synapse, ZAP-70 controls T cell polarization and recruitment of signaling proteins but not formation of the synaptic pattern. Immunity 2002; 17: 389399.
  • 33
    Dustin ML, Colman DR. Neural and immunological synaptic relations. Science 2002; 298: 785789.
  • 34
    Davis SJ, Van Der Merwe PA. The immunological synapse: required for T cell receptor signalling or directing T cell effector function? Curr Biol 2001; 11: 289291.
  • 35
    Lee SJ, Hori Y, Groves JT, Dustin ML, Chakraborty AK. Correlation of a dynamic model for immunological synapse formation with effector functions: two pathways to synapse formation. Trends Immunol 2002; 23: 492499.
  • 36
    Radoja S, Saio M, Schaer D, Koneru M, Vukmanovic S, Frey AB. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. J Immunol 2001; 167: 50425051.
  • 37
    Viola A. The amplification of TCR signaling by dynamic membrane microdomains. Trends Immunol 2001; 22: 322327.
  • 38
    Cherukuri A, Dykstra M, Pierce SK. Floating the raft hypothesis: lipid rafts play a role in immune cell activation. Immunity 2001; 14: 657660.
  • 39
    Xavier R, Brennan T, Li Q, McCormack C, Seed B. Membrane compartmentation is required for efficient T cell activation. Immunity 1998; 8: 723732.
  • 40
    Germain RN. The T cell receptor for antigen: signaling and ligand discrimination. J Biol Chem 2001; 276: 3522335226.
  • 41
    Stoddart A, Dykstra ML, Brown BK, Song W, Pierce SK, Brodsky FM. Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization. Immunity 2002; 17: 451462.
  • 42
    Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, Mittler RS. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 1996; 4: 535543.
  • 43
    Egen JG, Allison JP. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 2002; 16: 2335.
  • 44
    Darlington PJ, Baroja ML, Chau TA et al. Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation. J Exp Med 2002; 195: 13371347.
  • 45
    Chikuma S, Imboden JB, Bluestone JA. Negative regulation of T cell receptor–lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2003; 197: 129135.
  • 46
    Demetriou M, Granovsky M, Quaggin S, Dennis JW. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001; 409: 733739.
  • 47
    Lee KM, Chuang E, Griffin M et al. Molecular basis of T cell inactivation by CTLA-4. Science 1998; 282: 22632266.
  • 48
    Calvo CR, Amsen D, Kruisbeek AM. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J Exp Med 1997; 186: 16451653.
  • 49
    Zhang W, Trible RP, Samelson LE. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 1998; 9: 239246.
  • 50
    Chuang E, Fisher TS, Morgan RW et al. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 2000; 13: 313322.
  • 51
    Baroja ML, Vijayakrishnan L, Bettelli E et al. Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J Immunol 2002; 168: 50705078.
  • 52
    Martin M, Schneider H, Azouz A, Rudd CE. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J Exp Med 2001; 194: 16751681.
  • 53
    Dupre L, Aiuti A, Trifari S et al. Wiskott–Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 2002; 17: 157166.
  • 54
    Raab M, Pfister S, Rudd CE. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity 2001; 15: 921933.
  • 55
    Wulfing C, Davis MM. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science 1998; 282: 22662269.
  • 56
    Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 1999; 283: 680682.
  • 57
    Michel F, Attal-Bonnefoy G, Mangino G, Mise-Omata S, Acuto O. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 2001; 15: 935945.
  • 58
    Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice. CTLA4 can function independently of CD28. J Exp Med 1998; 188: 199204.
  • 59
    Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225252.
  • 60
    Yamada A, Kishimoto K, Dong VM et al. CD28-independent costimulation of T cells in alloimmune responses. J Immunol 2001; 167: 140146.
  • 61
    Mandelbrot DA, Oosterwegel MA, Shimizu K et al. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4. J Clin Invest 2001; 107: 881887.
  • 62
    Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein D. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol 2001; 2: 5863.
  • 63
    Grohmann U, Orabona C, Fallarino F et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002; 3: 10971101.
  • 64
    Metz DP, Farber DL, Taylor T, Bottomly K. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation. J Immunol 1998; 161: 58555861.
  • 65
    Bour-Jordan H, Grogan JL, Tang Q, Auger JA, Locksley RM, Bluestone JA. CTLA-4 regulates the requirement for cytokine-induced signals in T (H) 2 lineage commitment. Nat Immunol 2003; 4: 182188.
  • 66
    Kato T, Nariuchi H. Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation. J Immunol 2000; 164: 35543562.
  • 67
    Oosterwegel MA, Mandelbrot DA, Boyd SD et al. The role of CTLA-4 in regulating Th2 differentiation. J Immunol 1999; 163: 26342639.
  • 68
    Sho M, Yamada A, Najafian N et al. Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size. J Immunol 2002; 169: 37443751.
  • 69
    Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 2000; 164: 512521.
  • 70
    Taylor PA, Noelle RJ, Blazar BR. CD4(+) CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 13111318.
  • 71
    Griffin MD, Hong DK, Holman PO et al. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152). J Immunol 2000; 164: 44334442.
  • 72
    Frauwirth KA, Riley JL, Harris MH et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002; 16: 769777.
  • 73
    Schneider H, Martin M, Agarraberes FA et al. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J Immunol 1999; 163: 18681879.
  • 74
    Oki S, Kohsaka T, Azuma M. Augmentation of CTLA-4 expression by wortmannin: involvement of lysosomal sorting properties of CTLA-4. Int Immunol 1999; 11: 15631571.
  • 75
    Barrat FJ, Le Deist F, Benkerrou M et al. Defective CTLA-4 cycling pathway in Chediak–Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation. Proc Natl Acad Sci USA 1999; 96: 86458650.
  • 76
    Millward TA, Zolnierowicz S, Hemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999; 24: 186191.